These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24043136)

  • 41. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
    Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H
    Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
    Morita T; Matsuzaki A; Tokue A
    Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
    Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
    Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    O'connor T; Rustum Y; Levine E; Creaven P
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Capecitabine in carcinoma of the pancreas.
    Smith DB; Neoptolemos JP
    Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing.
    do Nascimento RS; Nagamine MK; De Toledo GF; Chaible LM; Tedardi MV; Del-Grande MP; da Fonseca IIM; Dagli MLZ
    Anticancer Drugs; 2021 Feb; 32(2):111-116. PubMed ID: 33395068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
    Temmink OH; Prins HJ; van Gelderop E; Peters GJ
    Br J Cancer; 2007 Jan; 96(1):61-6. PubMed ID: 17179993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
    Bonotto M; Bozza C; Di Loreto C; Osa EO; Poletto E; Puglisi F
    Clin Breast Cancer; 2013 Jun; 13(3):167-72. PubMed ID: 23218471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
    Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.
    Petrioli R; Bargagli G; Lazzi S; Pascucci A; Francini E; Bellan C; Conca R; Martellucci I; Fiaschi AI; Lorenzi B; Francini G;
    Anticancer Drugs; 2010 Mar; 21(3):313-9. PubMed ID: 20016369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.
    Pusztai L; Zhen JH; Arun B; Rivera E; Whitehead C; Thompson WJ; Nealy KM; Gibbs A; Symmans WF; Esteva FJ; Booser D; Murray JL; Valero V; Smith TL; Hortobagyi GN
    J Clin Oncol; 2003 Sep; 21(18):3454-61. PubMed ID: 12972520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lapatinib: new drug. For some women with metastatic breast cancer.
    Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400
    [No Abstract]   [Full Text] [Related]  

  • 54. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.
    Di Gennaro E; Piro G; Chianese MI; Franco R; Di Cintio A; Moccia T; Luciano A; de Ruggiero I; Bruzzese F; Avallone A; Arra C; Budillon A
    Br J Cancer; 2010 Nov; 103(11):1680-91. PubMed ID: 21045833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.
    Endo M; Miwa M; Eda H; Ura M; Tanimura H; Ishikawa T; Miyazaki-Nose T; Hattori K; Shimma N; Yamada-Okabe H; Ishitsuka H
    Int J Cancer; 2003 Sep; 106(5):799-805. PubMed ID: 12866042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.
    Terranova-Barberio M; Roca MS; Zotti AI; Leone A; Bruzzese F; Vitagliano C; Scogliamiglio G; Russo D; D'Angelo G; Franco R; Budillon A; Di Gennaro E
    Oncotarget; 2016 Feb; 7(7):7715-31. PubMed ID: 26735339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
    Hattori K; Kohchi Y; Oikawa N; Suda H; Ura M; Ishikawa T; Miwa M; Endoh M; Eda H; Tanimura H; Kawashima A; Horii I; Ishitsuka H; Shimma N
    Bioorg Med Chem Lett; 2003 Mar; 13(5):867-72. PubMed ID: 12617910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Capecitabine in advanced gastric cancer.
    Okines A; Chau I; Cunningham D
    Expert Opin Pharmacother; 2007 Nov; 8(16):2851-61. PubMed ID: 17956204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
    Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
    Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
    Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
    Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.